{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:32:24Z","timestamp":1794634344443,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1C1B6003389"],"award-info":[{"award-number":["NRF-2018R1C1B6003389"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00432-023-05387-6","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:02:26Z","timestamp":1695801746000},"page":"17093-17102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cancer risks in patients with psoriasis administered biologics therapy: a nationwide population-based study"],"prefix":"10.1007","volume":"149","author":[{"given":"Joon Min","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"5387_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM (2021) Psoriasis prevalence in adults in the United States. JAMA Dermatol 157:940\u2013946. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2007","journal-title":"JAMA Dermatol"},{"key":"5387_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2230.1993.tb02236.x","volume":"18","author":"SM Bhate","year":"1993","unstructured":"Bhate SM, Sharpe GR, Marks JM, Shuster S, Ross WM (1993) Prevalence of skin and other cancers in patients with psoriasis. Clin Exp Dermatol 18:401\u2013404. https:\/\/doi.org\/10.1111\/j.1365-2230.1993.tb02236.x","journal-title":"Clin Exp Dermatol"},{"key":"5387_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP (2015) Psoriasis. Lancet 386:983\u2013994. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","journal-title":"Lancet"},{"key":"5387_CR4","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285. https:\/\/doi.org\/10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"key":"5387_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1684\/ejd.2018.3288","volume":"28","author":"L Brambilla","year":"2018","unstructured":"Brambilla L, Genovese G, Tourlaki A, Della Bella S (2018) Coexistence of Kaposi\u2019s sarcoma and psoriasis: is there a hidden relationship? Eur J Dermatol 28:320\u2013325. https:\/\/doi.org\/10.1684\/ejd.2018.3288","journal-title":"Eur J Dermatol"},{"key":"5387_CR6","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/jid.2009.113","volume":"129","author":"YB Brauchli","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR (2009) Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 129:2604\u20132612. https:\/\/doi.org\/10.1038\/jid.2009.113","journal-title":"J Invest Dermatol"},{"key":"5387_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","volume":"72","author":"GR Burmester","year":"2013","unstructured":"Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP (2013) Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn\u2019s disease. Ann Rheum Dis 72:517\u2013524. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201244","journal-title":"Ann Rheum Dis"},{"key":"5387_CR8","first-page":"3833","volume":"117","author":"T Calzascia","year":"2007","unstructured":"Calzascia T, Pellegrini M, Hall H, Sabbagh L, Ono N, Elford AR, Mak TW, Ohashi PS (2007) TNF-\u03b1 is critical for antitumor but not antiviral T cell immunity in mice. J Clin Investig 117:3833\u20133845","journal-title":"J Clin Investig"},{"key":"5387_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaad.2010.04.046","volume":"65","author":"YJ Chen","year":"2011","unstructured":"Chen YJ, Wu CY, Chen TJ, Shen JL, Chu SY, Wang CB, Chang YT (2011) The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 65:84\u201391. https:\/\/doi.org\/10.1016\/j.jaad.2010.04.046","journal-title":"J Am Acad Dermatol"},{"key":"5387_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamadermatol.2015.4847","volume":"152","author":"ZC Chiesa Fuxench","year":"2016","unstructured":"Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, Gelfand JM (2016) The risk of cancer in patients with psoriasis: a population-based cohort study in the health improvement network. JAMA Dermatol 152:282\u2013290. https:\/\/doi.org\/10.1001\/jamadermatol.2015.4847","journal-title":"JAMA Dermatol"},{"key":"5387_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","volume":"6","author":"GP Dunn","year":"2006","unstructured":"Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836\u2013848","journal-title":"Nat Rev Immunol"},{"key":"5387_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/jdv.13619","volume":"30","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Thyssen JP, Gislason GH, Skov L (2016) Skin cancer in patients with psoriasis. J Eur Acad Dermatol Venereol 30:1349\u20131353. https:\/\/doi.org\/10.1111\/jdv.13619","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5387_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1365-2133.1999.02655.x","volume":"140","author":"G Frentz","year":"1999","unstructured":"Frentz G, Olsen JH (1999) Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 140:237\u2013242. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02655.x","journal-title":"Br J Dermatol"},{"key":"5387_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/ard.2004.030528","volume":"64","author":"P Geborek","year":"2005","unstructured":"Geborek P, Bladstr\u00f6m A, Turesson C, Gulfe A, Petersson IF, Saxne T, Olsson H, Jacobsson LT (2005) Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64:699\u2013703. https:\/\/doi.org\/10.1136\/ard.2004.030528","journal-title":"Ann Rheum Dis"},{"key":"5387_CR15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","volume":"141","author":"JM Gelfand","year":"2005","unstructured":"Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141:1537\u20131541. https:\/\/doi.org\/10.1001\/archderm.141.12.1537","journal-title":"Arch Dermatol"},{"key":"5387_CR16","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","volume":"126","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB (2006) The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126:2194\u20132201. https:\/\/doi.org\/10.1038\/sj.jid.5700410","journal-title":"J Invest Dermatol"},{"key":"5387_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5021\/ad.2020.32.2.115","volume":"32","author":"SP Ham","year":"2020","unstructured":"Ham SP, Oh JH, Park HJ, Kim JU, Kim HY, Jung SY, Choi SY, Seol JE, Kim H, Kim MS, Lee UH, Choi M, Park HJ (2020) Validity of diagnostic codes for identification of psoriasis patients in Korea. Ann Dermatol 32:115\u2013121. https:\/\/doi.org\/10.5021\/ad.2020.32.2.115","journal-title":"Ann Dermatol"},{"key":"5387_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","volume":"114","author":"A Hannuksela-Svahn","year":"2000","unstructured":"Hannuksela-Svahn A, Pukkala E, L\u00e4\u00e4r\u00e4 E, Poikolainen K, Karvonen J (2000) Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 114:587\u2013590. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00898.x","journal-title":"J Invest Dermatol"},{"key":"5387_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/art.37740","volume":"65","author":"K Haynes","year":"2013","unstructured":"Haynes K, Beukelman T, Curtis JR, Newcomb C, Herrinton LJ, Graham DJ, Solomon DH, Griffin MR, Chen L, Liu L, Saag KG, Lewis JD (2013) Tumor necrosis factor \u03b1 inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum 65:48\u201358. https:\/\/doi.org\/10.1002\/art.37740","journal-title":"Arthritis Rheum"},{"key":"5387_CR20","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1002\/ijc.27376","volume":"131","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K (2012) Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease. Int J Cancer 131:E326\u2013E328. https:\/\/doi.org\/10.1002\/ijc.27376","journal-title":"Int J Cancer"},{"key":"5387_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/jdv.14610","volume":"32","author":"P Jensen","year":"2018","unstructured":"Jensen P, Egeberg A, Gislason G, Thyssen JP, Skov L (2018) Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study. J Eur Acad Dermatol Venereol 32:601\u2013605. https:\/\/doi.org\/10.1111\/jdv.14610","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5387_CR22","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/sj.bjc.6605027","volume":"100","author":"J Ji","year":"2009","unstructured":"Ji J, Shu X, Sundquist K, Sundquist J, Hemminki K (2009) Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 100:1499\u20131502. https:\/\/doi.org\/10.1038\/sj.bjc.6605027","journal-title":"Br J Cancer"},{"key":"5387_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","volume":"11","author":"YS Jung","year":"2017","unstructured":"Jung YS, Han M, Park S, Kim WH, Cheon JH (2017) Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study. J Crohns Colitis 11:954\u2013962. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx040","journal-title":"J Crohns Colitis"},{"key":"5387_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, Im JS, Seo HG (2022) Cancer Statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat 54:330\u2013344. https:\/\/doi.org\/10.4143\/crt.2022.128","journal-title":"Cancer Res Treat"},{"key":"5387_CR25","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.4049\/jimmunol.163.10.5358","volume":"163","author":"Y Kashii","year":"1999","unstructured":"Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 163:5358\u20135366","journal-title":"J Immunol"},{"key":"5387_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000519560","volume":"103","author":"T Kobayashi","year":"2022","unstructured":"Kobayashi T, Udagawa E, Hibi T (2022) Lack of increased risk of lymphoma with thiopurine therapy regardless of dose and duration of treatment in Japanese patients with inflammatory bowel diseases. Digestion 103:169\u2013173. https:\/\/doi.org\/10.1159\/000519560","journal-title":"Digestion"},{"key":"5387_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/heapol\/czn037","volume":"24","author":"S Kwon","year":"2009","unstructured":"Kwon S (2009) Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage. Health Policy Plan 24:63\u201371. https:\/\/doi.org\/10.1093\/heapol\/czn037","journal-title":"Health Policy Plan"},{"key":"5387_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M (2006) IL-23 promotes tumour incidence and growth. Nature 442:461\u2013465","journal-title":"Nature"},{"key":"5387_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1346-8138.14698","volume":"46","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kim HJ, Han KD, Kim HN, Park YM, Lee JY, Park YG, Lee YB (2019) Cancer risk in 892 089 patients with psoriasis in Korea: a nationwide population-based cohort study. J Dermatol 46:95\u2013102. https:\/\/doi.org\/10.1111\/1346-8138.14698","journal-title":"J Dermatol"},{"key":"5387_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/11587890-000000000-00000","volume":"12","author":"C Leonardi","year":"2011","unstructured":"Leonardi C, Papp K, Strober B, Reich K, Asahina A, Gu Y, Beason J, Rozzo S, Tyring S (2011) The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials. Am J Clin Dermatol 12:321\u2013337. https:\/\/doi.org\/10.2165\/11587890-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"5387_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/0190-9622(90)70152-8","volume":"22","author":"B Lindel\u00f6f","year":"1990","unstructured":"Lindel\u00f6f B, Eklund G, Lid\u00e9n S, Stern RS (1990) The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 22:1056\u20131060. https:\/\/doi.org\/10.1016\/0190-9622(90)70152-8","journal-title":"J Am Acad Dermatol"},{"key":"5387_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","volume":"8","author":"MD Long","year":"2010","unstructured":"Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD (2010) Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 8:268\u2013274. https:\/\/doi.org\/10.1016\/j.cgh.2009.11.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5387_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MD Long","year":"2012","unstructured":"Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD (2012) Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 143:390-399.e391. https:\/\/doi.org\/10.1053\/j.gastro.2012.05.004","journal-title":"Gastroenterology"},{"key":"5387_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/2012.jama.10857","volume":"308","author":"MA Lopez-Olivo","year":"2012","unstructured":"Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME (2012) Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308:898\u2013908. https:\/\/doi.org\/10.1001\/2012.jama.10857","journal-title":"JAMA"},{"key":"5387_CR35","first-page":"778","volume":"137","author":"D Margolis","year":"2001","unstructured":"Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL (2001) The risk of malignancy associated with psoriasis. Arch Dermatol 137:778\u2013783","journal-title":"Arch Dermatol"},{"key":"5387_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/ard.2009.117762","volume":"69","author":"X Mariette","year":"2010","unstructured":"Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, Heresbach D, Martin A, Schaeverbeke T, Salmon D, Lemann M, Hermine O, Raphael M, Ravaud P (2010) Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis 69:400\u2013408. https:\/\/doi.org\/10.1136\/ard.2009.117762","journal-title":"Ann Rheum Dis"},{"key":"5387_CR37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.it.2013.07.004","volume":"34","author":"SF Ngiow","year":"2013","unstructured":"Ngiow SF, Teng MW, Smyth MJ (2013) A balance of interleukin-12 and -23 in cancer. Trends Immunol 34:548\u2013555. https:\/\/doi.org\/10.1016\/j.it.2013.07.004","journal-title":"Trends Immunol"},{"key":"5387_CR38","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.jaad.2010.07.026","volume":"66","author":"KA Papp","year":"2012","unstructured":"Papp KA, Poulin Y, Bissonnette R, Bourcier M, Toth D, Rosoph L, Poulin-Costello M, Setterfield M, Syrotuik J (2012) Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population. J Am Acad Dermatol 66:e33\u2013e45. https:\/\/doi.org\/10.1016\/j.jaad.2010.07.026","journal-title":"J Am Acad Dermatol"},{"key":"5387_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bjd.12214","volume":"168","author":"KA Papp","year":"2013","unstructured":"Papp KA, Griffiths CE, Gordon K, Lebwohl M, Szapary PO, Wasfi Y, Chan D, Hsu MC, Ho V, Ghislain PD, Strober B, Reich K (2013) Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol 168:844\u2013854. https:\/\/doi.org\/10.1111\/bjd.12214","journal-title":"Br J Dermatol"},{"key":"5387_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaad.2011.07.040","volume":"67","author":"DM Pariser","year":"2012","unstructured":"Pariser DM, Leonardi CL, Gordon K, Gottlieb AB, Tyring S, Papp KA, Li J, Baumgartner SW (2012) Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis. J Am Acad Dermatol 67:245\u2013256. https:\/\/doi.org\/10.1016\/j.jaad.2011.07.040","journal-title":"J Am Acad Dermatol"},{"key":"5387_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","volume":"120","author":"CF Paul","year":"2003","unstructured":"Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L (2003) Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120:211\u2013216. https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12040.x","journal-title":"J Invest Dermatol"},{"issue":"Suppl 3","key":"5387_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.12165","volume":"27","author":"C Pouplard","year":"2013","unstructured":"Pouplard C, Brenaut E, Horreau C, Barnetche T, Misery L, Richard MA, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Ma\u00eetre M, Ortonne JP, Paul C (2013) Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol 27(Suppl 3):36\u201346. https:\/\/doi.org\/10.1111\/jdv.12165","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5387_CR43","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.4049\/jimmunol.164.7.3645","volume":"164","author":"A Pr\u00e9vost-Blondel","year":"2000","unstructured":"Pr\u00e9vost-Blondel A, Roth E, Rosenthal FM, Pircher H (2000) Crucial role of TNF-\u03b1 in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol 164:3645\u20133651","journal-title":"J Immunol"},{"key":"5387_CR44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1185\/030079906X104641","volume":"22","author":"D Robinson","year":"2006","unstructured":"Robinson D, Hackett M, Wong J, Kimball AB, Cohen R, Bala M (2006) Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001\u20132002. Curr Med Res Opin 22:989\u20131000. https:\/\/doi.org\/10.1185\/030079906X104641","journal-title":"Curr Med Res Opin"},{"key":"5387_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136974","volume":"10","author":"TN Sergentanis","year":"2015","unstructured":"Sergentanis TN, Tsivgoulis G, Perlepe C, Ntanasis-Stathopoulos I, Tzanninis IG, Sergentanis IN, Psaltopoulou T (2015) Obesity and risk for brain\/CNS tumors, gliomas and meningiomas: a meta-analysis. PLoS ONE 10:e0136974. https:\/\/doi.org\/10.1371\/journal.pone.0136974","journal-title":"PLoS ONE"},{"key":"5387_CR46","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.22056","volume":"54","author":"S Setoguchi","year":"2006","unstructured":"Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S (2006) Tumor necrosis factor \u03b1 antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 54:2757\u20132764. https:\/\/doi.org\/10.1002\/art.22056","journal-title":"Arthritis Rheum"},{"key":"5387_CR47","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-4362.1997.00284.x","volume":"36","author":"JD Stratigos","year":"1997","unstructured":"Stratigos JD, Potouridou I, Katoulis AC, Hatziolou E, Christofidou E, Stratigos A, Hatzakis A, Stavrianeas NG (1997) Classic Kaposi\u2019s sarcoma in Greece: a clinico-epidemiological profile. Int J Dermatol 36:735\u2013740. https:\/\/doi.org\/10.1046\/j.1365-4362.1997.00284.x","journal-title":"Int J Dermatol"},{"key":"5387_CR48","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288\u20131294. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.03.012","journal-title":"J Clin Epidemiol"},{"key":"5387_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/art.30310","volume":"63","author":"AE Thompson","year":"2011","unstructured":"Thompson AE, Rieder SW, Pope JE (2011) Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum 63:1479\u20131485. https:\/\/doi.org\/10.1002\/art.30310","journal-title":"Arthritis Rheum"},{"key":"5387_CR50","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","volume":"155","author":"AM Trafford","year":"2019","unstructured":"Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, Ashcroft DM (2019) Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis. JAMA Dermatol 155:1390\u20131403. https:\/\/doi.org\/10.1001\/jamadermatol.2019.3056","journal-title":"JAMA Dermatol"},{"key":"5387_CR51","first-page":"471","volume":"36","author":"HW Tseng","year":"2018","unstructured":"Tseng HW, Lu LY, Lam HC, Tsai KW, Huang WC, Shiue YL (2018) The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan. Clin Exp Rheumatol 36:471\u2013478","journal-title":"Clin Exp Rheumatol"},{"key":"5387_CR52","first-page":"650","volume":"48","author":"N Watanabe","year":"1988","unstructured":"Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I (1988) Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Can Res 48:650\u2013653","journal-title":"Can Res"},{"key":"5387_CR53","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740\u20131751. https:\/\/doi.org\/10.1002\/art.20311","journal-title":"Arthritis Rheum"},{"key":"5387_CR54","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/art.22864","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56:2886\u20132895. https:\/\/doi.org\/10.1002\/art.22864","journal-title":"Arthritis Rheum"},{"key":"5387_CR55","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.mayocp.2015.03.024","volume":"90","author":"S Yadav","year":"2015","unstructured":"Yadav S, Singh S, Harmsen WS, Edakkanambeth Varayil J, Tremaine WJ, Loftus EV (2015) Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from Olmsted County, Minnesota. Mayo Clin Proc 90:738\u2013746. https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.024","journal-title":"Mayo Clin Proc"},{"key":"5387_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028530","volume":"10","author":"J Yan","year":"2018","unstructured":"Yan J, Smyth MJ, Teng MWL (2018) Interleukin (IL)-12 and IL-23 and their conflicting roles in cancer. Cold Spring Harb Perspect Biol 10:a028530. https:\/\/doi.org\/10.1101\/cshperspect.a028530","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T17:02:33Z","timestamp":1700326953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":56,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5387"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05387-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared. Neither this manuscript nor one with substantially similar content under our authorship has been presented or published elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of Asan Medical Center approved this study (2021-0377).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"The funding sources had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder\/sponsor"}}]}}